40% of all type 2 diabetics will develop diabetic nephropathy (DN), which is the leading cause of end stage kidney failure in Australia and around the world.

The study aims to investigate whether an inflammatory molecule called suPAR is elevated in diabetic kidney disease, and whether it can be used as a marker for early detection of atherosclerosis or cardiovascular disease in type II diabetic patients.

Researchers 

Conjoint Associate Professor Alastair Gillies, Zaw Thet 

Research Area 
Project type 
Project Grant
Year of funding 
2014